Skip to main content
. Author manuscript; available in PMC: 2019 Oct 5.
Published in final edited form as: Eur J Med Chem. 2018 Sep 11;158:478–492. doi: 10.1016/j.ejmech.2018.09.029

Fig.1.

Fig.1

The design of novel phenylalanine derivatives as HIV-1 CA inhibitors. (a) Structure of PF-74; (b) The binding mode of PF-74 in the binding site of CA protein hexamer. Red dashed lines indicate H-bond interactions.